LYNNWOOD, Wash., July 17, 2024 /PRNewswire/ -- Volpara Health Technologies Ltd., a leader in cancer detection software, announces key executive changes to enhance customer success and drive growth. Craig Hadfield is now Chief Customer and Financial Officer (CCFO), and Becky Weber joins as Executive Vice President of Sales.

华盛顿州林恩伍德（LYNNWOOD），2024年7月17日/PRNewswire/--Volpara Health Technologies Ltd.，癌症检测软件的领导者，宣布了关键的高管变更，以提高客户成功率并推动增长。克雷格·哈德菲尔德（CraigHadfield）现任首席客户兼财务官（CCFO），贝基·韦伯（BeckyWeber）出任销售执行副总裁。

Following Lunit's strategic acquisition of Volpara in May 2024, Teri Thomas has been named Chief Business Officer of Lunit's Cancer Screening Group while continuing as CEO of Volpara..

在Lunit于2024年5月战略性收购Volpara后，Teri Thomas被任命为Lunit癌症筛查集团的首席商务官，同时继续担任Volpara的首席执行官。。

'The promotion of Craig Hadfield to CCFO and the appointment of Becky Weber as EVP of Sales align Volpara around creating compelling customer value and driving revenue growth,' said Volpara CEO and Lunit CBO Teri Thomas. 'Our new partnership with Lunit enables us to grow and evolve our leadership team around key business priorities.

Volpara首席执行官兼Lunit CBO Teri Thomas说，Craig Hadfield被提升为CCFO，Becky Weber被任命为销售副总裁，这使Volpara能够创造引人注目的客户价值并推动收入增长我们与Lunit的新合作关系使我们能够围绕关键业务重点发展和发展我们的领导团队。

By delivering a customer-connected experience unlike any others in our industry, we create a cycle where satisfied customers drive more revenue and foster further innovation.'.

通过提供与我们行业中任何其他公司不同的与客户相关的体验，我们创造了一个周期，让满意的客户带来更多收入并促进进一步的创新。”。

Craig Hadfield - Chief Customer and Financial Officer (CCFO)

Craig Hadfield-首席客户兼财务官（CCFO）

Craig Hadfield, formerly Chief Financial Officer at Volpara Health, now takes on the expanded role of Chief Customer and Financial Officer, underscoring Volpara's focus on compelling customer value, and linking financial leadership with customer relationship enhancement. Craig has relocated from New Zealand to Seattle to deeply engage with Volpara's extensive customer base in the US.

前Volpara Health首席财务官克雷格·哈德菲尔德（CraigHadfield）现在承担起首席客户和财务官的扩大角色，强调Volpara专注于引人注目的客户价值，并将财务领导力与客户关系增强联系起来。克雷格已从新西兰迁至西雅图，与Volpara在美国的广泛客户群进行深入接触。

He will continue leading finance while overseeing customer operations..

他将继续领导财务，同时监督客户运营。。

Becky Weber - Executive Vice President of Sales

Becky Weber-销售执行副总裁

Becky Weber joins Volpara as Executive Vice President of Sales, bringing over 15 years of health tech experience from Epic, Apple, Able Health, and Health Catalyst. At Apple, she developed cutting-edge health apps for WatchOS. Becky also has an extensive track record of partnering with prominent healthcare institutions to achieve their population health and revenue objectives, all while ensuring exceptional customer experiences.

贝基·韦伯（BeckyWeber）加入Volpara担任销售执行副总裁，为Epic、Apple、Able health和health Catalyst带来了超过15年的健康技术经验。在苹果，她为WatchOS开发了尖端的健康应用程序。贝基还与著名的医疗保健机构合作，以实现其人口健康和收入目标，同时确保卓越的客户体验。

Becky's role at Volpara will center on driving sales strategies and expanding market presence, leveraging her extensive customer engagement background to foster growth and innovation..

Becky在Volpara的角色将集中于推动销售战略和扩大市场占有率，利用她广泛的客户参与背景来促进增长和创新。。

'By acquiring Volpara, Lunit has created a powerhouse in AI-driven cancer detection and care,' said Thomas. 'The multiply effect of combining Lunit's AI technology with Volpara's established presence in breast cancer screening expertise enables us to deliver superior cancer screening solutions, elevate customer care and promote mutual growth.'.

托马斯说：“通过收购Volpara，Lunit在人工智能驱动的癌症检测和护理领域创造了一个强大的平台。”。

About Volpara Health

关于Volpara Health

Volpara Health is on a mission to save families from cancer with AI-powered software that helps healthcare providers better understand cancer risk, guide personalized care decisions, and recommend additional imaging and interventions. Used in over 2,000 facilities by more than 5,600 technologists worldwide.

Volpara Health的使命是通过人工智能驱动的软件帮助家庭远离癌症，该软件可以帮助医疗保健提供者更好地了解癌症风险，指导个性化护理决策，并建议额外的成像和干预措施。全世界5600多名技术人员在2000多个设施中使用。

Volpara's software impacts nearly 17M patients, supports over 3M annual cancer risk assessments, and integrates seamlessly with electronic health records and imaging systems. Volpara helps radiologists quantify dense breast tissue with precision and technologists produce mammograms with optimal positioning, compression, and dose.

Volpara的软件影响了近1700万名患者，支持每年超过300万次的癌症风险评估，并与电子健康记录和成像系统无缝集成。Volpara帮助放射科医生精确地量化致密的乳房组织，技术人员制作具有最佳定位，压缩和剂量的乳房X线照片。

Volpara software also streamlines operations to ease compliance and accreditation. Volpara was acquired by Lunit in 2024 and is headquartered in Wellington, New Zealand, with an office in Seattle. Volpara is the trusted partner of leading healthcare institutions globally. For more information, visit www.volparahealth.com..

Volpara软件还简化了操作，以简化法规遵从性和认证。Volpara于2024年被Lunit收购，总部位于新西兰惠灵顿，在西雅图设有办事处。Volpara是全球领先医疗机构值得信赖的合作伙伴。有关更多信息，请访问www.volparahealth.com。。

About Lunit

长滩

Founded in 2013, Lunit is a medical AI company on a mission to conquer cancer. We harness AI-powered medical image analytics and AI biomarkers to ensure accurate diagnosis and optimal treatment for each cancer patient. Our FDA-cleared Lunit INSIGHT suite for cancer screening serves over 3,000 hospitals and medical institutions across 40+ countries.

Lunit成立于2013年，是一家致力于征服癌症的医疗AI公司。我们利用人工智能支持的医学图像分析和人工智能生物标志物，确保每位癌症患者的准确诊断和最佳治疗。我们经FDA批准的Lunit INSIGHT癌症筛查套件为40多个国家的3000多家医院和医疗机构提供服务。

Our clinical findings are featured in top journals, including the Journal of Clinical Oncology and the Lancet Digital Health, and presented at global conferences such as the ASCO and RSNA. In 2024, Lunit acquired Volpara Health Technologies, setting the stage for unparalleled synergy and accuracy, particularly in breast health and screening technologies.

我们的临床发现在顶级期刊上发表，包括《临床肿瘤学杂志》和《柳叶刀数字健康》，并在ASCO和RSNA等全球会议上发表。2024年，Lunit收购了Volpara Health Technologies，为无与伦比的协同作用和准确性奠定了基础，特别是在乳房健康和筛查技术方面。

Headquartered in Seoul, South Korea, with a global network of offices, Lunit leads in medical AI innovation. Discover more at lunit.io.

Lunit总部位于韩国首尔，拥有全球办公室网络，在医疗AI创新方面处于领先地位。在lunit.io上了解更多信息。

SOURCE Volpara Health, Inc.

来源Volpara Health，Inc。